Literature DB >> 1136939

Effects of dexamethasone on myocardial cells in the early phase of acute myocardial infarction.

J A Spath, A M Lefer.   

Abstract

Dexamethasone exerted no significant hemodynamic effect in sham-operated cats or in cats subjected to acute myocardial ischemia. However, the glucoccortcoid did normalize elevated S-T segments toward pre-ischemic values, and prevented much of the increase in plasma CPK activity following coronary artery ligation. Moreover, dexamethasone prevented loss of CPK activity and restricted the loss of lysosomal hydrolase within ischemic myocardial tissue. These data indicate that lysosomal disruption is an early consequence of myocardial ischemia and that treatment with dexamethasone prevents the loss of myocardial lysosomal and cellular enzymes as reflected in normalization of the ECG and plasma CPK activity of ischemic cats. In this way, dexamethasone may act to retard the spread of the developing infarct within the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1136939     DOI: 10.1016/0002-8703(75)90256-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Protective effect of methylprednisolone on ischaemic myocardium assessed by ventricular function.

Authors:  B L Krause; M A Hassan; A B McMilan; A H Brown
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

2.  Hepatic blood flow in acute myocardial ischemia.

Authors:  M J Galvin; A M Lefer
Journal:  Experientia       Date:  1979-12-15

3.  Morphometric observations on the rat heart after high-dose treatment with cortisol.

Authors:  G Mall; H Reinhard; D Stopp; J A Rossner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

4.  Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin.

Authors:  W Song; B L Furman; J R Parratt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 5.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

6.  The measurement and control of myocardial infarct size.

Authors:  M C Apps; J Tinker
Journal:  Intensive Care Med       Date:  1978-01       Impact factor: 17.440

7.  Anabolic-androgenic steroid does not enhance compensatory muscle hypertrophy but significantly diminish muscle damages in the rat surgical ablation model.

Authors:  Tetsuro Tamaki; Yoshiyasu Uchiyama; Yoshinori Okada; Kayoko Tono; Masahiro Nitta; Akio Hoshi; Akira Akatsuka
Journal:  Histochem Cell Biol       Date:  2009-03-25       Impact factor: 4.304

8.  Influence of methylprednisolone of the sequential redistribution of cathepsin D and other lysosomal enzymes during myocardial ischemia in rabbits.

Authors:  R S Decher; A R Poole; J T Dingle; K Wildenthal
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

9.  Reduction of ischemic myocardial damage in the dog by lidocaine infusion.

Authors:  R G Schaub; G Stewart; M Strong; R Ruotolo; G Lemoie
Journal:  Am J Pathol       Date:  1977-05       Impact factor: 4.307

10.  Glucocorticoids preserve the t-tubular system in ventricular cardiomyocytes by upregulation of autophagic flux.

Authors:  Thomas Seidel; Dominik J Fiegle; Tim J Baur; Anne Ritzer; Sandra Nay; Christian Heim; Michael Weyand; Hendrik Milting; Robert H Oakley; John A Cidlowski; Tilmann Volk
Journal:  Basic Res Cardiol       Date:  2019-10-31       Impact factor: 12.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.